Reporting of industry funded study outcome data: comparison of confidential and published data on the safety and effectiveness of rhBMP-2 for spinal fusion
暂无分享,去创建一个
L. Stewart | J. Higgins | M. Simmonds | M. Rodgers | R. Mannion | M. Heirs | J. Brown | Morag K. Heirs | Mark A. Rodgers
[1] H. Woo,et al. 127 Carotid Revascularization for Stenosis Improves Blood Flow and Executive Cognitive Function , 2014 .
[2] Mark C Simmonds,et al. Safety and Effectiveness of Recombinant Human Bone Morphogenetic Protein-2 for Spinal Fusion , 2013, Annals of Internal Medicine.
[3] Tom Jefferson,et al. The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience , 2012, PLoS medicine.
[4] S. Glassman,et al. Blood Serum Antibody Analysis and Long-Term Follow-up of Patients Treated With Recombinant Human Bone Morphogenetic Protein-2 in the Lumbar Spine , 2011, Spine.
[5] R. Dryer,et al. Lumbar Disc Arthroplasty With MAVERICK Disc Versus Stand-Alone Interbody Fusion: A Prospective, Randomized, Controlled, Multicenter Investigational Device Exemption Trial , 2011, Spine.
[6] Bradley K Weiner,et al. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. , 2011, The spine journal : official journal of the North American Spine Society.
[7] E. Roon,et al. Low quality of reporting adverse drug reactions in paediatric randomised controlled trials , 2010, Archives of Disease in Childhood.
[8] T. Smoljanović,et al. Six-year outcomes of anterior lumbar interbody arthrodesis with use of interbody fusion cages and recombinant human bone morphogenetic protein-2. , 2010, The Journal of bone and joint surgery. American volume.
[9] C. Fisher,et al. Evaluation of an rhBMP-2 Formulation in 2-level Posterolateral Lumbar Spine Arthrodesis , 2010 .
[10] P. Dahm,et al. Reporting of harm in randomized controlled trials published in the urological literature. , 2009, The Journal of urology.
[11] M. Grocott,et al. Quality of reporting in randomized trials published in high-quality surgical journals. , 2009, Journal of the American College of Surgeons.
[12] Isabelle Boutron,et al. Reporting of safety results in published reports of randomized controlled trials. , 2009, Archives of internal medicine.
[13] H. Bae,et al. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial. , 2009, The Journal of bone and joint surgery. American volume.
[14] S. Glassman,et al. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis. , 2009, The Journal of bone and joint surgery. American volume.
[15] D. Polly,et al. Outcome of lumbar arthrodesis in patients sixty-five years of age or older. , 2009, The Journal of bone and joint surgery. American volume.
[16] V. Alt,et al. An economic analysis of using rhBMP-2 for lumbar fusion in Germany, France and UK from a societal perspective , 2009, European Spine Journal.
[17] V. Alt,et al. PHC5 A COST-EFFECTIVENESS ANALYSIS OF RHBMP-2 IN SPINE FUSION SURGERY IN THE NETHERLANDS , 2008 .
[18] H. Bae,et al. 18. Level-1 Data Comparing rhBMP-2/ACS Combined with an Osteoconductive Bulking Agent with Iliac Crest Bone Graft in Posterolateral Lumbar Fusion , 2007 .
[19] R. Dryer,et al. 1. Maverick™ Total Disc Replacement versus Anterior Lumbar Interbody Fusion with the INFUSE® Bone Graft /LT-CAGE® Device: A Prospective, Randomized, Controlled, Multicenter IDE Trial , 2007 .
[20] R. Hurlbert,et al. A Long-term Radiographic and Clinical Evaluation of a New rhBMP-2 Formulation in a Prospective Randomized Lumbar Posterolateral Spine Fusion Study , 2007 .
[21] S. Boden,et al. The Efficacy of rhBMP-2 for Posterolateral Lumbar Fusion in Smokers , 2007, Spine.
[22] S. Glassman,et al. Clinical Outcomes and Fusion Success at 2 Years of Single-Level Instrumented Posterolateral Fusions With Recombinant Human Bone Morphogenetic Protein-2/Compression Resistant Matrix Versus Iliac Crest Bone Graft , 2006, Spine.
[23] S. Boden,et al. Evaluation of an Recombinant Human Bone Morphogenetic Protein-2/Ceramic Matrix as an Iliac Crest Bone Graft Replacement in Posterolateral Fusion: A Multicenter, Level I Clinical Study: 818 , 2006, Neurosurgery.
[24] J. Burkus,et al. Influence of rhBMP-2 on the Healing Patterns Associated With Allograft Interbody Constructs in Comparison With Autograft , 2006, Spine.
[25] G. Lanzino,et al. Successful Intra-arterial Basilar Artery Thrombolysis in a Patient with Bilateral Vertebral Artery Occlusion: Technical Case Report , 2005, Neurosurgery.
[26] John R. Johnson,et al. Initial Fusion Rates With Recombinant Human Bone Morphogenetic Protein-2/Compression Resistant Matrix and a Hydroxyapatite and Tricalcium Phosphate/Collagen Carrier in Posterolateral Spinal Fusion , 2005, Spine.
[27] S. Shapiro,et al. 809 A Randomized Trial of Instrumented Posterior Lumbar Interbody Fusion Using Machined Cortical Wedges/Local Bone with or without rhBMP2 in the Treatment of Degenerative Lumbar Spondylolisthesis with Stenosis. , 2005, Neurosurgery.
[28] J. Burkus,et al. Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. , 2005, The Journal of bone and joint surgery. American volume.
[29] M. Boakye,et al. Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein. , 2005, Journal of neurosurgery. Spine.
[30] C. Branch,et al. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. , 2004, The spine journal : official journal of the North American Spine Society.
[31] J. Burkus. Bone morphogenetic proteins in anterior lumbar interbody fusion: old techniques and new technologies. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. , 2004, Journal of neurosurgery. Spine.
[32] David S Baskin,et al. A Prospective, Randomized, Controlled Cervical Fusion Study Using Recombinant Human Bone Morphogenetic Protein-2 With the CORNERSTONE-SR™ Allograft Ring and the ATLANTIS™ Anterior Cervical Plate , 2003, Spine.
[33] T. Zdeblick,et al. Is INFUSE Bone Graft Superior to Autograft Bone? An Integrated Analysis of Clinical Trials Using the LT-CAGE Lumbar Tapered Fusion Device , 2003, Journal of spinal disorders & techniques.
[34] J. Burkus,et al. Radiographic Assessment of Interbody Fusion Using Recombinant Human Bone Morphogenetic Protein Type 2 , 2003, Spine.
[35] S. Boden,et al. Use of Recombinant Human Bone Morphogenetic Protein-2 to Achieve Posterolateral Lumbar Spine Fusion in Humans: A Prospective, Randomized Clinical Pilot Trial 2002 Volvo Award in Clinical Studies , 2002, Spine.
[36] R. Balderston,et al. Clinical and Radiographic Outcomes of Anterior Lumbar Interbody Fusion Using Recombinant Human Bone Morphogenetic Protein-2 , 2002, Spine.
[37] C. Dickman,et al. Anterior Lumbar Interbody Fusion Using rhBMP-2 With Tapered Interbody Cages , 2002, Journal of spinal disorders & techniques.
[38] T. Kleeman,et al. Laparoscopic Anterior Lumbar Interbody Fusion With rhBMP-2: A Prospective Study of Clinical and Radiographic Outcomes , 2001, Spine.
[39] C. Dickman,et al. 751 A Prospective Randomized Lumbar Fusion Study Comparing rhBMP-2 with Autograft for Cage ALIF , 2001 .
[40] S. Boden,et al. The Use of rhBMP-2 in Interbody Fusion Cages: Definitive Evidence of Osteoinduction in Humans: A Preliminary Report , 2000, Spine.
[41] 克也 平山,et al. A prospective randomized trial , 1995 .
[42] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[43] M. Sherman,et al. A Preliminary Report , 1953 .